Month: October 2017

 

New study explores how herpes simplex virus may change during familial transmission

A new study explores how herpes simplex virus might change when passed from one individual to another, information that may prove useful in future development of therapeutics and vaccines.

Powered by WPeMatico

Study identifies predictors of poor outcomes in Duchenne muscular dystrophy patients

A new study from UT Southwestern suggests that more people with Duchenne muscular dystrophy could live longer by identifying and more aggressively treating patients with certain risk factors.

Powered by WPeMatico

Story-based videos hold promise for encouraging Latinas to seek help for anxiety and depression

A UCLA Nursing professor has found that culturally tailored multimedia content holds great promise for encouraging Latina woman to seek help for, and address the symptoms of, anxiety and depression.

Powered by WPeMatico

VUMC reaches new milestone after performing 2,000th liver transplant

This month, Vanderbilt University Medical Center performed its 2,000th liver transplant, another milestone for one of the largest liver transplant programs in the Southeast.

Powered by WPeMatico

Direct‐acting antiviral therapy linked to 71% reduction in liver cancer risk

A new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that eradication of the hepatitis C virus induced by direct‐acting antiviral medications is associated with a 71 percent reduction in the risk of liver cancer.

Powered by WPeMatico

Study finds increasing health care costs for patients with alcoholic cirrhosis

Health care costs for privately insured patients with alcoholic cirrhosis are nearly twice that of non‐alcoholic cirrhosis patients in the United States, according to research presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases.

Powered by WPeMatico

Researchers analyze frequency of mislabeling in herbal and dietary supplements

Herbal and dietary supplement mislabeling is common and should be evaluated as a potential cause for liver damage, according to research presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases.

Powered by WPeMatico

Study examines risk of using liver organs from hepatitis C positive donors

Use of liver organs from selected hepatitis C positive donors should be considered due to modest risk of hepatitis C transmission and the availability of safe and effective direct‐acting antiviral therapies, according to research presented this week at The Liver Meeting -; held by the American Association for the Study of Liver Diseases.

Powered by WPeMatico

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

A new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that daily aspirin therapy was significantly associated with a reduced risk in hepatitis B virus‐related liver cancer.

Powered by WPeMatico

Podcast: ‘What the health?’ whiplash

The bipartisan leaders of the Senate Health, Education, Labor and Pensions Committee this week agreed on a bill they say could help stabilize the struggling health insurance exchanges.

Powered by WPeMatico